CHRONIC MYELOMONOCYTIC LEUKEMIA-2
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA-2 explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA-2 trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests an experimental oral drug called LP-118 in up to 100 adults with blood cancers like leukemia, lymphoma, or multiple myeloma that have come back or not responded to other treatments. The main goals are to find the safest dose and see if the drug can shrink tumors …
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-2
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 26, 2026 10:12 UTC
-
New hope for tough blood cancers: first human trial launches
Disease control Recruiting nowThis early-stage study tests a new drug called STX-0712 in people with advanced chronic myelomonocytic leukemia (CMML) or acute myeloid leukemia (AML) who have run out of standard treatments. The main goals are to find a safe dose and check for side effects. About 105 participant…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-2
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated May 26, 2026 10:04 UTC